Issue 369 | September 12, 2017

    
Latest News: Spotlight One
Hollin: Value Assessment Frameworks Should Represent a Spectrum of Patient Preferences

Health Economist: Public Should Have Role in Drug Pricing

Report: Big Pharma Company Helped Fuel Opioid Epidemic

Could DACA’s End Lead to Public Health Crisis?

Medicaid Could Help Address Social Determinants of Health

Editorial: When It Comes to the Drug Pricing Debate, Talk Is Cheap

California Senate Could Vote on Drug Transparency Bill

The Journey to Value

How Can a New Value Framework Impact Orphan Drug Woes?

Departing Novartis CEO Eyes Silicon Valley; What Next?

Spotlight Two
Special thanks to our partners:
Conference of the Week Webinar of the Week Latest Jobs


Associate Director of Value Strategy and Communications

Health Economist

Research Associate I/II - Health Preferences

Research Scientist - Outcomes Research/Health Preferences

Senior Research Associate – Modeling and Simulation - Health Economics

Pricing and Market Access Associate Director

Director/Senior Director, HEOR, HE Modeling

Link of the Week Job of the Week
Upcoming Conferences Upcoming Webinars
9th Semi-Annual Managed Markets and Account Management Strategies Conference
September 14-15
Chicago, Illinois

ISPOR 6th Latin America Conference
September 15-17
Sao Paulo, Brazil

ACO Leadership and Strategic Governance Forum
September 18-19
Dallas, Texas

Social Media: A Rich Data Source or a Can of Worms? A Guide to the Use of Health-Related Social Media in the Pharmaceutical Industry
September 13

Estimating Health-State Utility for Economic Models in Clinical Studies
September 14

Big Data and Cognitive Computing: The Next Generation of RWE for Rheumatologic and Related Immunologic Disorders
September 20


FORWARD THIS EMAIL TO A FRIEND | SUBSCRIBE TO OUR NEWSLETTERS | CONTACT US

Xcendaeyeforpharma eMaxHealth Evidera Curo Jefferson HealthCoreTruven Doctor Evidence Quintiles IMS Humana OM1 Parexel Evidence Partners DRG Abacus MAPS G&J Lee Recruitment